This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6yx1
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of SHANK1 PDZ in complex with a peptide-small molecule hybrid== | ==Crystal structure of SHANK1 PDZ in complex with a peptide-small molecule hybrid== | ||
| - | <StructureSection load='6yx1' size='340' side='right'caption='[[6yx1]]' scene=''> | + | <StructureSection load='6yx1' size='340' side='right'caption='[[6yx1]], [[Resolution|resolution]] 1.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YX1 OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6yx1]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YX1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6YX1 FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ARG:ARGININE'>ARG</scene>, <scene name='pdbligand=LEU:LEUCINE'>LEU</scene>, <scene name='pdbligand=PWT:2-[[2-(5-oxidanylidenepentanoyl)hydrazinyl]methyl]benzoic+acid'>PWT</scene>, <scene name='pdbligand=THR:THREONINE'>THR</scene></td></tr> |
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[6ywz|6ywz]], [[6yx0|6yx0]], [[6yx2|6yx2]]</div></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">SHANK1 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6yx1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yx1 OCA], [https://pdbe.org/6yx1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6yx1 RCSB], [https://www.ebi.ac.uk/pdbsum/6yx1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6yx1 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[https://www.uniprot.org/uniprot/SHAN1_HUMAN SHAN1_HUMAN]] Seems to be an adapter protein in the postsynaptic density (PSD) of excitatory synapses that interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and Homer, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction. | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | beta-Strand mediated protein-protein interactions (PPIs) represent underexploited targets for chemical probe development despite representing a significant proportion of known and therapeutically relevant PPI targets. beta-Strand mimicry is challenging given that both amino acid side-chains and backbone hydrogen-bonds are typically required for molecular recognition, yet these are oriented along perpendicular vectors. This paper describes an alternative approach, using GKAP/SHANK1 PDZ as a model and dynamic ligation screening to identify small-molecule replacements for tranches of peptide sequence. A peptide truncation of GKAP functionalized at the N- and C-termini with acylhydrazone groups was used as an anchor. Reversible acylhydrazone bond exchange with a library of aldehyde fragments in the presence of the protein as template and in situ screening using a fluorescence anisotropy (FA) assay identified peptide hybrid hits with comparable affinity to the GKAP peptide binding sequence. Identified hits were validated using FA, ITC, NMR and X-ray crystallography to confirm selective inhibition of the target PDZ-mediated PPI and mode of binding. These analyses together with molecular dynamics simulations demonstrated the ligands make transient interactions with an unoccupied basic patch through electrostatic interactions, establishing proof-of-concept that this unbiased approach to ligand discovery represents a powerful addition to the armory of tools that can be used to identify PPI modulators. | ||
| + | |||
| + | Identification of beta-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation.,Hegedus Z, Hobor F, Shoemark DK, Celis S, Lian LY, Trinh CH, Sessions RB, Edwards TA, Wilson AJ Chem Sci. 2021 Jan 6;12(6):2286-2293. doi: 10.1039/d0sc05694d. PMID:34163995<ref>PMID:34163995</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 6yx1" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Celis S]] | + | [[Category: Celis, S]] |
| - | [[Category: Edwards | + | [[Category: Edwards, T A]] |
| - | [[Category: Hegedus Z]] | + | [[Category: Hegedus, Z]] |
| - | [[Category: Hobor F]] | + | [[Category: Hobor, F]] |
| - | [[Category: Lian | + | [[Category: Lian, L J]] |
| - | [[Category: Sessions | + | [[Category: Sessions, R B]] |
| - | [[Category: Shoemark | + | [[Category: Shoemark, D K]] |
| - | [[Category: Trinh | + | [[Category: Trinh, C H]] |
| - | [[Category: Wilson | + | [[Category: Wilson, A J]] |
| + | [[Category: Beta-sheets acylhydrazone]] | ||
| + | [[Category: Fragment-based drug discovery]] | ||
| + | [[Category: Hybrid structure]] | ||
| + | [[Category: Pdz domain]] | ||
| + | [[Category: Peptide binding protein]] | ||
| + | [[Category: Protein protein interaction]] | ||
Revision as of 10:09, 7 July 2021
Crystal structure of SHANK1 PDZ in complex with a peptide-small molecule hybrid
| |||||||||||
Categories: Human | Large Structures | Celis, S | Edwards, T A | Hegedus, Z | Hobor, F | Lian, L J | Sessions, R B | Shoemark, D K | Trinh, C H | Wilson, A J | Beta-sheets acylhydrazone | Fragment-based drug discovery | Hybrid structure | Pdz domain | Peptide binding protein | Protein protein interaction
